Does ENZALUTAMIDE Cause International normalised ratio increased? 38 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of International normalised ratio increased have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.1% of all adverse event reports for ENZALUTAMIDE.
38
Reports of International normalised ratio increased with ENZALUTAMIDE
0.1%
of all ENZALUTAMIDE reports
2
Deaths
19
Hospitalizations
How Dangerous Is International normalised ratio increased From ENZALUTAMIDE?
Of the 38 reports, 2 (5.3%) resulted in death, 19 (50.0%) required hospitalization, and 2 (5.3%) were considered life-threatening.
Is International normalised ratio increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause International normalised ratio increased?
WARFARIN (5,622)
RIVAROXABAN (863)
ACETAMINOPHEN (533)
ASPIRIN (448)
APIXABAN (317)
CLOPIDOGREL BISULFATE (314)
FLUINDIONE (286)
AMIODARONE (277)
FUROSEMIDE (277)
DABIGATRAN ETEXILATE (223)
Which ENZALUTAMIDE Alternatives Have Lower International normalised ratio increased Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE